ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

ClinicalTrials.gov ID: NCT06140303

Public ClinicalTrials.gov record NCT06140303. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers. Closure Obtained With Vascularized Epithelial Regeneration for DFUs With SkinTE® II (COVER DFUS II)

Study identification

NCT ID
NCT06140303
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
PolarityTE
Industry
Enrollment
100 participants

Conditions and interventions

Conditions

Interventions

  • Control Other
  • SkinTE Biological

Other · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 21, 2024
Primary completion
Dec 30, 2025
Completion
Mar 30, 2026
Last update posted
Jul 10, 2025

2024 – 2026

United States locations

U.S. sites
23
U.S. states
9
U.S. cities
22
Facility City State ZIP Site status
Titan Clinical Research Mesa Arizona 85202
Center for Clinical Research Castro Valley California 94546
Limb Preservation Platform, Inc. Fresno California 93710
Angel City Research Los Angeles California 90010
Clemente Clinical Research Inc. Los Angeles California 92704
Center for Clinical Research San Francisco California 94115
Clemente Clinical Research Inc. Santa Ana California 92704
ILD Research Vista California 92081
Las Mercedes Medical Research, Inc. Hialeah Florida 33010
Doctors Research Network Miami Florida 33156
DMI Research Pinellas Park Florida 33782
Barry University Clinical Research Tamarac Florida 33321
FASMA - Hagerstown Hagerstown Maryland 21742
Viable Research Management Henderson Nevada 89014
Northwell Health, Inc. New Hyde Park New York 11042
Mount Sinai West Hospital New York New York 10019
LEIRT (Lower Extremity Institute for Research and Therapy) Boardman Ohio 44512
Cutting Edge Research LLC Circleville Ohio 43123
LEIRT (Lower Extremity Institute for Research and Therapy) East Liverpool Ohio 43920
Cutting Edge Research LLC Grove City Ohio 43123
Perfizien Clinical Research LLC. Houston Texas 77055
Baylor Scott & White Health Plano Texas 75093
Foot and Ankle Specialists of the Mid-Atlantic Salem Virginia 24153

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06140303, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06140303 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →